Jump to: navigation, search

Chronic myelomonocytic leukemia

2 bytes added, 13:06, 20 May 2018
Text replacement - "" to ""
|[http Grövdal et al. 2010]
|style="background-color:#91cf61"|Phase II
# Grövdal M, Karimi M, Khan R, Aggerholm A, Antunovic P, Astermark J, Bernell P, Engström LM, Kjeldsen L, Linder O, Nilsson L, Olsson A, Holm MS, Tangen JM, Wallvik J, Oberg G, Hokland P, Jacobsen SE, Porwit A, Hellström-Lindberg E. Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy. Br J Haematol. 2010 Aug;150(3):293-302. Epub 2010 May 20. [http link to original article] '''contains verified protocol''' [ PubMed] content property of []
[[Category:Chronic myelomonocytic leukemia regimens]]
[[Category:Disease-specific pages]]
[[Category:Myeloproliferative neoplasms]]
LookupUsers, editors, emailconfirmed, Administrators

Navigation menu